跳至主要内容
临床试验/ISRCTN88319802
ISRCTN88319802已完成不适用

Magnetic resonance imaging study of the genital tract distribution and retention of microbicide 0.5% PRO 2000/5 Gel (P) in vivo: a partially blinded, randomised, two-arm, single-centre study

niversity of York (UK)0 个研究点目标入组 20 人开始时间: 2009年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Female participants:
  • 1. Aged 18 - 45 years. The upper age of 45 is felt to be important due to the need for female participants to have a regular menstrual cycle.
  • 2. Sexually active with a current, stable, regular male partner
  • 3. Not currently using condoms with this partner. This is important so that it is acceptable to randomise a participant to not using condoms.
  • 4. Using hormonal contraception (except hormone-releasing intrauterine devices [IUDs])
  • 5. Not known to be allergic to gadolinium
  • 6. Willing and able to adhere to the study conditions and methodology
  • 7. Willing and able to give written and signed informed consent to trial participation and procedures
  • 8. Willing to use condoms in the context of the trial
  • 9. Willing to have a human immunodeficiency virus (HIV) test (venous blood, HIV antibody test)
  • Male partners:
  • 1. Aged 18 - 55 years. The upper age limit for men is felt to be appropriate to minimise age related conditions.
  • 2. Independently reports that they are not currently using condoms with this partner
  • 3. Not known to be allergic to gadolinium (as the male partner may come into contact with gadolinium during the act of unprotected coitus for study purposes)
  • 4. Willing and able to adhere to the study conditions and methodology
  • 5. Willing and able to give written informed consent to trial participation and procedures
  • 6. Willing to use condoms in the context of the trial
  • 7. Willing to have a HIV test (venous blood, HIV antibody test)

排除标准

  • Females only:
  • 1. Pregnancy or lactation
  • 2. Gynaecological instrumentation and procedures of the cervix/uterus in the last three months including cervical polypectomy, dilatation and curettage, endometrial biopsy, loop excision, etc.
  • 3. Contraindication to MRI such as intracerebral aneurysm clip or implanted electronic devices
  • 4. Currently participating in, or having participated in the last 3 months prior to the first screening visit, any other vaginal microbicide or mucosal vaccine study or clinical trial of an investigational agent
  • Females and males:
  • 1. Untreated syphilis, gonorrhoea, trichomonas, chlamydia, candida or bacterial vaginosis
  • 2. Current genital tract infection
  • 3. HIV infection
  • 4. Active hepatitis B or C infection
  • 5. History of coagulation disorders
  • 6. Significant haematological, biochemical, or coagulation assay abnormalities on screening
  • 7. Unlikely to comply with protocol

研究者

发起方
niversity of York (UK)

相似试验